Common pain point
Each 340B covered entity must ensure program integrity and maintain accurate records that comply with program requirements, while also being subject to audit by the manufacturer and the federal government. Studies show that more than half of the adverse findings in 2016 HRSA audits are linked to a prescription generated outside the responsibility of the covered entity.
With eRx Eligibility Check, covered entities have improved capture rates by combining Sentrex core data sets and the ePrescription file within Sentry’s 340B solution suite, and have tightened eligibility checks for prescriptions and patient service locations.
Complete the form below to request a demo and see why you can expect more with Sentry.